IM- LTS: An Integrated Model for Lung Tumor Segmentation using Neural Networks and IoMT.

MethodsX

Department of Computing Technologies, School of Computing, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.

Published: June 2025

In recent days, Internet of Medical Things (IoMT) and Deep Learning (DL) techniques are broadly used in medical data processing in decision-making. A lung tumour, one of the most dangerous medical diseases, requires early diagnosis with a higher precision rate. With that concern, this work aims to develop an Integrated Model (IM- LTS) for Lung Tumor Segmentation using Neural Networks (NN) and the Internet of Medical Things (IoMT). The model integrates two architectures, MobileNetV2 and U-NET, for classifying the input lung data. The input CT lung images are pre-processed using Z-score Normalization. The semantic features of lung images are extracted based on texture, intensity, and shape to provide information to the training network.•In this work, the transfer learning technique is incorporated, and the pre-trained NN was used as an encoder for the U-NET model for segmentation. Furthermore, Support Vector Machine is used here to classify input lung data as benign and malignant.•The results are measured based on the metrics such as, specificity, sensitivity, precision, accuracy and F-Score, using the data from benchmark datasets. Compared to the existing lung tumor segmentation and classification models, the proposed model provides better results and evidence for earlier disease diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869539PMC
http://dx.doi.org/10.1016/j.mex.2025.103201DOI Listing

Publication Analysis

Top Keywords

lung tumor
12
tumor segmentation
12
input lung
12
im- lts
8
integrated model
8
lung
8
segmentation neural
8
neural networks
8
internet medical
8
medical things
8

Similar Publications

Background: Few malignancies provoke as many controversies about treatment as pleural mesothelioma. There is limited experience with novel radiotherapy techniques worldwide in adjuvant and particularly in neoadjuvant settings within multimodality treatment. The objective of the current study was to investigate the long-term outcome of neoadjuvant and adjuvant pleural intensity-modulated radiotherapy (IMRT) combined with macroscopic complete resection with or without chemotherapy.

View Article and Find Full Text PDF

Non-small cell lung cancer (NSCLC) is a complex disease with diverse clinical and molecular characteristics. Since the discovery of the oncogenic neurotrophic receptor tyrosine kinase (NTRK) gene fusion in colorectal cancer in 1986, its understanding has gradually progressed. NTRK's relevance is crucial to understanding some tumor development and how specific tyrosine receptor kinase inhibitors (TRKI) work.

View Article and Find Full Text PDF

Background: Bone metastasis (BoM) is common in advanced cancer, but its incidence in pleural mesothelioma (PM) remains unclear. This study aimed to determine the incidence of BoM in PM patients and assess its prognosis and risk factors to clarify its clinical significance.

Methods: A retrospective analysis was conducted on 515 histologically confirmed PM patients enrolled between January 2011 and December 2020.

View Article and Find Full Text PDF

Background: The development of immunotherapy has led to a paradigm shift in the treatment of malignant tumors. Immune checkpoint inhibitors (ICIs) function by blocking the receptors and ligands of T cells from binding one another, empowering them to target and attack cancer cells. ICIs along with other immunotherapy treatments, have seen a significant increase in usage in recent years.

View Article and Find Full Text PDF
Article Synopsis
  • GREM1 is linked to tumor progression and poor prognosis in lung adenocarcinoma (LUAD), which is a common and aggressive form of lung cancer.
  • The study uses various analyses, including gene expression data and survival analysis, to demonstrate that higher levels of GREM1 are associated with worse patient outcomes and influence the immune microenvironment.
  • Experimental results show that GREM1 promotes LUAD cell growth and movement, highlighting its potential as a target for future therapies in personalized cancer treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!